Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Skip
Best For

How This Company Makes Money

Dividend Snapshot GSK

Max Ratio

Dividend Yield

3.71 %

5Y Dividend Growth

-17.00 %

Consecutive Years

2 years

5Y Average Payout Ratio

68.94 %

Dividend History GSK

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 3.71 %
Consecutive Years 2
Forward Annual Dividend 1.81 USD
Consistent Years 2
Dividend CAGR 3Y -43.26 %
Continuous Dividends 53
Dividend CAGR 5Y -3.76 %
Payout Ratio TTM 74.72 %
Dividend CAGR 10Y -3.54 %
Ex Dividend Date 08/14/2026

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Dividend Score

Sales Growth GSK

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin GSK

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income GSK

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM GSK

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio GSK

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

GlaxoSmithKline PLC ADR GSK

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself GSK

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 16.00
Forward PE 19.08
Enterprise Value Revenue 2.71
Price Sales TTM 3.07
Enterprise Value EBITDA 9.31
Price Book MRQ 4.25

Bottom Line

GlaxoSmithKline PLC ADR

GSK
Current price
48.63 USD -0.18 USD (-0.38%)
Last closed 48.54 USD
ISIN US37733W2044
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 101 882 724 352 USD
Yield for 12 month +20.07 %
1Y
3Y
5Y
10Y
15Y
GSK
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+32 667 000 000 USD

Last Year

+31 376 000 000 USD

Current Quarter

+8 409 000 000 USD

Last Quarter

+7 629 000 000 USD

Current Year

+23 650 000 000 USD

Last Year

+22 328 000 000 USD

Current Quarter

+6 143 000 000 USD

Last Quarter

+5 754 000 000 USD
EBITDA 10 817 999 872 USD
Operating Margin TTM 30.94 %
Price to Earnings 16.00
Return On Assets TTM 10.01 %
PEG Ratio 95.40
Return On Equity TTM 33.38 %
Wall Street Target Price 58.58 USD
Revenue TTM 33 202 999 296 USD
Book Value 11.98 USD
Revenue Per Share TTM 16.51 USD
Dividend Share 0.68 USD
Quarterly Revenue Growth YOY 5.30 %
Dividend Yield 3.71 %
Gross Profit TTM 24 401 999 872 USD
Earnings Per Share 3.18 USD
Diluted EPS TTM 3.18 USD
Most Recent Quarter II 2026
Quarterly Earnings Growth YOY -69.50 %
Profit Margin 14.52 %
Price to Free Cash Flow TTM 11.34

Technical Indicators GSK

For 52 Weeks

37.95 USD 60.11 USD
50 Day MA 51.70 USD
Shares Short Prior Month 13 759 806
200 Day MA 52.25 USD
Short Ratio 3.30
Shares Short 14 778 190
Short Percent 0.74 %